One in eight women will be diagnosed with breast cancer during her lifetime. The earlier cancer is detected, the better the chance of successful treatment and long-term survival. However, early cancer diagnosis is still challenging as testing by mammography remains cumbersome, costly, and in many cases, cancer can only be detected at an advanced stage. A team based in the Dept. of Biomedical Engineering at McGill University's Faculty of Medicine has developed a new microfluidics-based microarray that could one day radically change how and when cancer is diagnosed. Their findings are published in the April issue of the journal Molecular & Cellular Proteomics.
- Detecting breast cancer's fingerprint in a droplet of blood Thu, 5 Apr 2012, 18:08:11 EDT
- Heart disease beats breast cancer as the biggest killerSun, 19 Jun 2011, 20:31:26 EDT
- MRI detects breast cancer at earlier stageThu, 10 Dec 2009, 18:19:59 EST
- Palpable breast cancers are more common in women not undergoing annual mammographyMon, 15 Mar 2010, 12:32:43 EDT
- ASCO data show serum DNA blood tests detect cancers with high sensitivity and specificityMon, 7 Jun 2010, 9:59:12 EDT